wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57169149-87FE3FBF-DC36-4B90-B0CD-8CA24E5D3CA0
Q57169149-87FE3FBF-DC36-4B90-B0CD-8CA24E5D3CA0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57169149-87FE3FBF-DC36-4B90-B0CD-8CA24E5D3CA0
Biosimilars: Review of current applications, obstacles, and their future in medicine
P2860
Q57169149-87FE3FBF-DC36-4B90-B0CD-8CA24E5D3CA0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57169149-87FE3FBF-DC36-4B90-B0CD-8CA24E5D3CA0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5e9d217dadccb5b932b8d390d821251979b1c372
P2860
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.